AI Translation Pipeline for Pharma

The Problem

Pharmaceutical companies translate thousands of documents annually: SOPs (Standard Operating Procedures), quality procedures, promotional materials, regulatory submissions. The standard process involves external translation agencies with 2+ week turnaround times.

Pain Point	Business Impact
2+ week turnaround	Delays market launches, slows compliance updates
Agency queue dependency	Capacity constraints during peak periods
Manual handoff	Staff time on export/import/tracking
Cost per document	Translation fees compound across markets

For companies launching products across multiple markets, every week of translation delay means delayed market access. The question wasn’t whether AI translation was good enough - it was whether it could integrate into existing regulated workflows.

---

The Solution

Architecture

Key Technical Decisions

Decision	Rationale
Azure Document Translation	Format preservation (maintains tables, layouts), custom model support for domain terminology, batch processing capability
Veeva-native integration	Documents stay in the regulated content management system; no manual export/import; audit trail preserved
Human-in-the-loop	AI generates draft; domain experts validate. Required for regulated content, but validation is faster than creation

Pharma-Specific Requirements

Veeva Vault is the content management platform most large pharma companies use for regulated documents. The integration had to satisfy its regulatory constraints:

• Audit trail: All translations logged with timestamps and version history
• Version control: Source and translated documents linked in Vault
• Review workflow: Mandatory human validation before approval
• Terminology consistency: Custom glossaries for drug names, medical terms

---

Implementation

My Role

Area	Activities
Requirements	Gathered needs from both clients, translated business requirements into technical specs
Coordination	Bridged technical team and client stakeholders
Validation	Ran document samples through pipeline, assessed translation quality against reference
Handover	Documented everything for successor PM

Team Structure

• Me: Project management, business-tech liaison, testing coordination
• Technical team: Azure integration, Veeva workflow configuration
• Client SMEs (Subject Matter Experts): Document samples, validation criteria, domain expertise

Validation Approach

1. Collected representative documents from each client
2. Ran samples through Azure Document Translation
3. Compared output against existing agency translations
4. Identified pharma-specific terms requiring custom handling
5. End-to-end workflow testing in Veeva environment

Collected 30,000+ sentence pairs for custom model training and quality benchmarking.

---

Client Configurations

Client	Veeva Module	Document Types	Languages
European vaccine manufacturer	Vault Quality	SOPs, quality documents	EN↔DE, EN↔DA
Global pharmaceutical company	Vault PromoMats	Promotional materials	PT-BR↔EN

---

Results

Process Improvement

Metric	Before	After
Turnaround	Up to 2 weeks	Hours to days
Manual steps	Export → Agency → Track → Import	Trigger in Vault → Review
Scaling	Constrained by agency capacity	On-demand

Handover Success

Project was completed after my departure:

• Comprehensive documentation enabled continuity
• Successor PM confirmed first client deployment operational
• Foundation established for additional language pairs at second client

---

Lessons Learned

1. Integration is the hard part. Azure translation works well out of the box. Connecting it seamlessly to Veeva - preserving audit trails, maintaining version links, fitting into existing approval workflows - required careful design.

2. Domain terminology matters. Generic neural translation handles most content well, but drug names, medical terms, and regulatory language need custom glossaries.

3. Human review remains essential. AI translation accelerates the process but doesn’t eliminate expert validation for regulated content. The value shift: from paying for translation creation to streamlining translation validation.

4. Sample testing builds confidence. Running real documents through the system early identified edge cases and built stakeholder trust before full deployment.

---

Impact

For both clients, AI translation changed the economics of multilingual content:

• European vaccine manufacturer: Quality documents now reach European markets in days instead of weeks. Translation capacity is no longer a constraint during product launches.
• Global pharmaceutical company: The foundation is set for scaling promotional content across Latin American markets without proportional agency spend.

The broader shift: translation moved from an external dependency to an internal capability - one that improves with use as custom terminology builds up.

---

Want to discuss AI translation?

If your team is waiting weeks for translations in a regulated environment, there’s a faster way that still passes audit. Get in touch to discuss your document workflows.